Frequent urination, weak stream, and nighttime bathroom trips affect millions of men over 50. Soris Pain & Vascular Institute treats enlarged prostate with prostate artery embolization (PAE), a minimally invasive alternative to transurethral resection of the prostate (TURP) surgery that preserves sexual function.
Our physicians use catheter-based embolization to shrink prostate tissue without general anesthesia or a hospital stay.
An enlarged prostate compresses the urethra and triggers frequent urges to urinate. Men with BPH may visit the bathroom eight or more times per day.
Reduced urine flow, hesitancy at the start of urination, and intermittent stopping and starting indicate urethral compression from prostate enlargement.
Waking two or more times per night to urinate disrupts sleep quality and contributes to daytime fatigue. Soris Pain & Vascular Institute evaluates nocturia as a key BPH severity marker.
The sensation that the bladder has not fully emptied after urination leads to repeated trips and increases urinary tract infection risk.
BPH affects roughly 50 percent of men by age 60 and up to 90 percent by age 85. Prostate tissue growth accelerates with age as hormonal balance shifts.
Reference: Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3):474-9.
A first-degree relative with BPH doubles the likelihood of developing the condition. Obesity and physical inactivity correlate with larger prostate volumes and more severe urinary symptoms.
Prostate Artery Embolization (PAE) delivers microscopic particles through a catheter to the arteries feeding the enlarged prostate. Blocking these vessels reduces blood supply to the excess tissue, which shrinks over the following weeks. Soris Pain & Vascular performs PAE as an outpatient procedure under local anesthesia.
Alpha-blockers relax prostate smooth muscle and 5-alpha reductase inhibitors shrink prostate tissue over months. Soris Pain & Vascular recommends PAE when medications produce insufficient relief or intolerable side effects.
TURP and other surgical approaches remove prostate tissue directly. These procedures require general anesthesia and carry higher risks of retrograde ejaculation and incontinence compared to PAE.
Related Conditions
BPH shares symptom overlap with prostate cancer, urinary tract infections, and overactive bladder. Soris Pain & Vascular Institute ensures accurate diagnosis before recommending embolization.
FAQ
PAE uses a catheter inserted through the wrist artery to deliver tiny particles that block blood flow to the enlarged prostate. The prostate shrinks over several weeks, relieving urinary symptoms. Soris Pain & Vascular performs PAE without general anesthesia.
PAE preserves sexual function. Clinical studies report that PAE has significantly lower rates of retrograde ejaculation and erectile dysfunction compared to TURP surgery.
Reference: Abt D, Hechelhammer L, Müllhaupt G, et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ. 2018;361:k2338.
Most patients notice symptom improvement within two to four weeks as the prostate shrinks. Peak results develop over three to six months. Soris Pain & Vascular schedules follow-up imaging to confirm volume reduction.
Board-certified physicians bringing hospital-level, minimally invasive interventional procedures to outpatient centers.
© 2026 Soris Pain & Vascular Institute. All rights reserved.
Pain management and vascular care marketing and web design by MDConsultingNY.